Kumba is a victim of the rand (and several other things). A big step forward for Nedbank in East Africa. Reinet's underperformance vs. British American Tobacco is incredible to witness. Sasol's business performance metrics for FY26 look encouraging.

SPAR is now a catastrophe. Dis-Chem's valuation makes it a sitting duck. Mediclinic is enjoying the benefit of operating leverage. Nampak was dragged down by one local segment. Aspen is considering share buybacks. African Media Entertainment is growing in a tough market. Delta Property Fund is making progress.

Weekly summary of corporate finance activity by South African exchange listed companies

The Foschini Group's share price is still sliding. Sephaku is a reminder of how regional the cement industry is. ASP Isotopes seems to be on the right side of Trump. ISA Holdings reported good numbers.

WeBuyCars was punished by the market. Old Mutual hosted a capital markets day. Ascendis wants to go private - again. Anglo, Kumba and Valterra Platinum released production updates. Balwin and Santova released results.

Weekly summary of Merger & Acquisition activity by South African companies

The MAS board has confirmed that the Prime Kapital bid is legally valid. Accelerate Property Fund is a complex speculative play. Thungela's earnings have plummeted. The Assura - Primary Health offer is in its final stages. ASP Isotopes will list later this month.

MAS shareholders have spoken - and Prime Kapital have a fight on their hands. Accelerate Property Fund is trying to tie up loose ends with related parties. Schroder's European portfolio is a mixed bag. Delta's disposal of 88 Field shows how CBDs have deteriorated.